GRUBER A/S

Danvak

Schneider Electric Danmark A/S

Phase III results approach for Cinclus – “We are hopeful”

Cinclus Pharma, which is developing new therapies for acid-related diseases, has now completed all planned patient visits in an ongoing Phase III trial. Prelimi...

GS1 Denmark

Tecsys A/S

Winncare Nordic ApS

Novo Nordisk licenses weight-loss pill in deal worth up to 2.6 billion dollars

Novo Nordisk has entered into an exclusive licensing agreement with Chinese pharmaceutical company Hengrui Pharma for HRS-1596, an oral GLP-1/GIP dual agonist w...

Expandia Moduler A/S

S.T.O.P. A/S

SorptionShade A/S

From Strategy to Start-Up: Preparing Clinical Studies for Success

Many innovative therapies and medical technologies face the same challenge: you know a clinical study is ahead, but you're not quite ready to start it yet.

Merck expands cancer pipeline with KRAS deal

Merck & Co has signed a licensing agreement worth up to $2.13 billion for global rights to a preclinical cancer drug candidate from Chinese biotech company SciB...

Egetis lands FDA approval: “Biggest milestone in the company’s history”

Swedish Egetis Therapeutics has secured FDA approval for its rare disease drug Emcitate, clearing the way for a US launch within weeks. “We are transitioning fr...

AstraZeneca bets $2bn on Summit’s cancer drug

AstraZeneca is investing 2 billion dollars in US-based Summit Therapeutics to accelerate the development of the cancer drug ivonescimab in combination with anti...

Elekta shows promising results in pancreatic cancer

Patients had localised pancreatic cancer but were not eligible for surgery. Following high-dose, MRI-guided radiotherapy with Elekta Unity, around 26 per cent w...

Biontech to close three factories in Germany – 1,800 employees affected

German pharmaceutical company Biontech will close its facilities in Tübingen, Marburg and Idar-Oberstein after failing to find buyers. Around 1,800 employees ar...

Swedish Alzheimer’s project wins 19 million dollar US research grant

An Alzheimer’s research project led by associate professor Sebastian Palmqvist at Lund University has been awarded 19.4 million dollars in US research funding. ...

AbbVie wins FDA approval for new Parkinson’s treatment

A new drug for Parkinson’s disease has been approved in the US

SciLifeLab set for major expansion in Stockholm

SciLifeLab is expanding its operations at Campus Solna by more than 9,000 square metres. Akademiska Hus is investing around SEK 230 million in the redevelopment...

ZEISS Medical Days 2026: See all highlights in one compact recap video

The video offers impressions from presentations, live demonstrations and discussions.

ResoTher eyes pharma deal as heart attack candidate moves forward

ResoTher Pharma is taking its lead candidate RTP-026 into a larger international study after seeing encouraging efficacy signals in patients with severe heart a...

After Phase III setback – Diamyd sees effect in long-term follow-up

Following its major Phase III setback earlier this year, Diamyd Medical is reporting new positive data. A long-term follow-up of an older study suggests that re...

Janne Backman takes over as chair of IRLAB

IRLAB Therapeutics has appointed a new board chair. Janne Backman succeeds Carola Lemne, who is stepping down after eight years on the research company’s board.